Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening - Report - MDSpire

Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening

  • By

  • Caitlin Kotian

  • Arshum Mirzaeifard

  • Elsa Wani

  • Karen Hock

  • Katherine Ashworth

  • Lindsey Sova

  • Roman Skoracki

  • Ann Scheck McAlearney

  • Electra D. Paskett

  • Tari King

  • Sara P. Myers

  • May 28, 2026

  • 0 min

Share

Clinical Report: Insights on Prospective Screening for Lymphedema in Breast Cancer

Overview

This qualitative study explores barriers to the implementation of prospective surveillance models (PSMs) for breast cancer-related lymphedema (BCRL) and identifies clinician-informed strategies to facilitate change. Key barriers include coordination challenges and clinician knowledge gaps, while proposed solutions emphasize education and standardized communication.

Background

Breast cancer-related lymphedema (BCRL) affects a significant proportion of breast cancer survivors, leading to chronic disability and decreased quality of life. Effective screening and early intervention through prospective surveillance models (PSMs) can mitigate the incidence of chronic BCRL. Understanding the barriers to implementing these models in routine clinical practice is essential for improving patient outcomes.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Barriers to PSM implementation include coordination challenges and limited patient understanding.
  • Clinicians perceive frequent surveillance visits as straining staffing capacity and contributing to financial toxicity.
  • Knowledge gaps regarding patient-reported outcomes (PROs) impact both preoperative and postoperative PSM appointments.
  • Strategies to address barriers include enhancing education for care teams and standardizing communication across oncology teams.
  • Thematic saturation was achieved after 17 clinician interviews, indicating comprehensive insights into the barriers and solutions.

Clinical Implications

Addressing the identified barriers to PSM implementation can enhance the effectiveness of lymphedema screening programs. Clinicians should prioritize education and communication strategies to improve patient engagement and streamline care processes.

Conclusion

This study highlights critical barriers to the implementation of PSMs for BCRL and offers actionable solutions to improve clinical practice. Continued efforts to refine these strategies are necessary for better patient outcomes.

Related Resources & Content

  1. The ASCO Post, 2020 -- Reducing the Risk of Lymphedema in Patients With Cancer
  2. The ASCO Post, 2019 -- Expert Point of View: Julie A. Margenthaler, MD Related Articles
  3. The ASCO Post, 2018 -- Expert Point of View: Sarah Blair, MD
  4. NCI, Lymphedema (PDQ®) - NCI
  5. Lymphology, 2023 -- THE DIAGNOSIS AND TREATMENT OF PERIPHERAL LYMPHEDEMA: 2023 CONSENSUS DOCUMENT OF THE INTERNATIONAL SOCIETY OF LYMPHOLOGY
  6. Journal of Clinical Oncology -- Prospective Surveillance for Breast Cancer–Related Arm Lymphedema: A Systematic Review and Meta-Analysis
  7. The ASCO Post — A Conversation with Constance M. Chen, MD, MPH
  8. Lymphedema (PDQ®) - NCI
  9. THE DIAGNOSIS AND TREATMENT OF PERIPHERAL LYMPHEDEMA: 2023 CONSENSUS DOCUMENT OF THE INTERNATIONAL SOCIETY OF LYMPHOLOGY | Lymphology
  10. Prospective Surveillance for Breast Cancer–Related Arm Lymphedema: A Systematic Review and Meta-Analysis | Journal of Clinical Oncology

Original Source(s)

Related Content